Free Newsletter
FDA draws back the veil
The transparency-minded FDA of Margaret Hamburg has taken the first step in its see-through makeover: the regulator has unveiled an Internet-based curriculum called "FDA Basics," aimed at helping site visitors understand what it does.
The Basics content--geared to the regulator's largest constituency, the American public--represents the first of three transparency phases; it's not until phase 3 that the regulator addresses its industry constituents.
The Basics curriculum resulted from recommendations made to the commissioner by a transparency task force, convened by her shortly after she became the 21st FDA commissioner last May. In the second phase of the initiative, the task force will make recommendations regarding public transparency of agency activities, with an eye toward protecting confidential information. Phase III, as mentioned, involves task force recommendations to the commissioner on FDA transparency to the industries it regulates.
- here's the FDA announcement
- see the FDA Basics content
Related Articles:
FDA boosts transparency to 77%
FDA reform advocates want trial, data transparency
FDA blog aims to chronicle transparency push
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: